MoneyWorks4Me

Godavari Biorefineries informs about updates

11 Aug 2026 Evaluate

Godavari Biorefineries has informed that the European Patent office has granted its patent application entitled ‘PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME’. The invention relates to a pharmaceutical composition comprising novel anti-cancer compounds in combination with a solubilising agent, and the process to prepare the same. The composition is designed to enhance the solubility and bioavailability of the active compounds, thereby improving their therapeutic potential. The composition has significant applications in the treatment of various cancers, including breast and prostate cancers, particularly through oral administration. The invention further covers the use of the pharmaceutical composition for the treatment and management of various cancers, thus strengthening the Company's oncology-focused intellectual property portfolio. Grant Certificate is attached.

The above information is a part of company’s filings submitted to BSE. 

Godavari Biorefineri Share Price

273.60 33.40 (13.91%)
11-Aug-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: